Haemonetics Corp (HAE)

Jan 14, 2025, 6:13 AM EST - 3 days ago

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Jan 8, 2025, 5:03 PM EST - 9 days ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Jan 6, 2025, 6:00 AM EST - 11 days ago

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 3, 2024, 1:16 AM EST - 6 weeks ago

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Nov 9, 2024, 1:34 AM EST - 2 months ago

Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript

Nov 7, 2024, 6:00 AM EST - 2 months ago

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Oct 3, 2024, 4:05 PM EDT - 3 months ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Aug 16, 2024, 7:57 AM EDT - 5 months ago

Top 3 Health Care Stocks That Are Set To Fly This Quarter

IBRX PGNY

Aug 15, 2024, 6:30 AM EDT - 5 months ago

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Aug 8, 2024, 1:13 PM EDT - 5 months ago

Haemonetics Corporation (HAE) Q1 2025 Earnings Call Transcript

Aug 8, 2024, 6:00 AM EDT - 5 months ago

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Jul 30, 2024, 6:00 AM EDT - 6 months ago

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

Jul 8, 2024, 4:05 PM EDT - 6 months ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Jun 21, 2024, 3:50 PM EDT - 7 months ago

Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth

Jun 18, 2024, 4:15 PM EDT - 7 months ago

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

May 23, 2024, 6:00 AM EDT - 8 months ago

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes

May 21, 2024, 4:05 PM EDT - 8 months ago

Haemonetics Announces Proposed Convertible Senior Notes Offering

May 10, 2024, 12:25 AM EDT - 9 months ago

Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript

May 9, 2024, 6:00 AM EDT - 9 months ago

Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Apr 10, 2024, 4:58 PM EDT - 10 months ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024

Apr 4, 2024, 6:30 AM EDT - 10 months ago

Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge

Apr 1, 2024, 8:00 AM EDT - 10 months ago

Haemonetics Corporation Completes Acquisition of Attune Medical

Mar 5, 2024, 6:00 AM EST - 11 months ago

Haemonetics Announces Definitive Agreement to Acquire Attune Medical

Feb 21, 2024, 5:57 PM EST - 11 months ago

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

Feb 21, 2024, 5:55 PM EST - 11 months ago

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Feb 8, 2024, 12:24 PM EST - 1 year ago

Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript

Feb 8, 2024, 6:00 AM EST - 1 year ago

Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Jan 11, 2024, 4:05 PM EST - 1 year ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024

Dec 12, 2023, 6:00 AM EST - 1 year ago

Haemonetics Corporation Completes Acquisition of OpSens Inc.

Dec 7, 2023, 4:05 PM EST - 1 year ago

Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Nov 22, 2023, 6:15 AM EST - 1 year ago

Haemonetics: Solid Performance Of This Blood Play

Nov 3, 2023, 6:21 PM EDT - 1 year ago

Haemonetics Corporation (HAE) Q2 2024 Earnings Call Transcript

Nov 2, 2023, 6:00 AM EDT - 1 year ago

Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Oct 13, 2023, 4:37 PM EDT - 1 year ago

Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment

Oct 10, 2023, 6:00 AM EDT - 1 year ago

Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.

Oct 5, 2023, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023

Aug 29, 2023, 6:30 AM EDT - 1 year ago

Haemonetics Announces European Expansion for VASCADE® Vascular Closure System

Aug 8, 2023, 11:43 AM EDT - 1 year ago

Haemonetics Corporation (HAE) Q1 2024 Earnings Call Transcript

Aug 8, 2023, 6:00 AM EDT - 1 year ago

Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Aug 7, 2023, 4:10 PM EDT - 1 year ago

Diane M. Bryant Joins Haemonetics' Board of Directors

Jul 10, 2023, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2024 Results: August 8, 2023

Jun 22, 2023, 6:15 AM EDT - 1 year ago

Haemonetics Receives FDA Clearance for Enhancements to NexSys PCS® Plasma Collection System

May 18, 2023, 1:20 PM EDT - 1 year ago

Haemonetics Corporation: Premium Blood Play

May 16, 2023, 5:43 AM EDT - 1 year ago

Haemonetics: Attracting Investment Through Capital Recycling Initiatives

May 11, 2023, 6:00 AM EDT - 1 year ago

Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Apr 25, 2023, 4:15 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023

Apr 20, 2023, 6:40 AM EDT - 1 year ago

Haemonetics Publishes Inaugural Corporate Responsibility Report

Mar 2, 2023, 6:35 AM EST - 2 years ago

Haemonetics Introduces Next Generation "Intelligent Control" Software for Cell Saver® Elite®+ Autotransfusion System

Feb 27, 2023, 4:05 PM EST - 2 years ago

Haemonetics to Present at Raymond James 44th Annual Institutional Investors Conference

Feb 15, 2023, 9:00 PM EST - 2 years ago

Haemonetics Executing Well, But Valuation Dogged By Concerns About A Large Customer